All posts by imreal

Cosmetic Procedure Interest Boom in the Zoom Age Highlights Benefits of Botox, Says Beverly Hills Physicians


Beverly Hills Physicians is a health and beauty medical group servicing Southern California.

It’s never a bad time to start the ball rolling on procedures in the future.

An April 22 article on Inside Hook reports on the sudden increase in cosmetic procedure interest since video conferencing became the leading form of communication. Due to the recent closure of physical offices because of new social distancing policies, video calls and meetings have vastly boosted the amount of time individuals unintentionally spend staring at themselves through the small, mirror-like box onscreen that often gives people an unflattering reflection of themselves. The article explains that, while individuals normally pay attention mostly to what others are saying in meetings or maybe gathering their thoughts for what they are going to say, now that their faces are staring back at them it’s hard not to dwell on the imperfections they see. Los Angeles-based health and beauty medical group Beverly Hills Physicians says that, while beauty treatments and procedures may be on hold for now, individuals can utilize this time to think about what they might like to have done and it’s never a bad time to start the ball rolling on procedures in the future.

Beverly Hills Physicians says that it can be hard to accept the fact that our appearances do matter to us a great deal. Whether it’s making a good first impression on a date or in an interview, the clinic says how a person presents themself can make or break an opportunity. Beverly Hills Physicians notes an individual’s appearance also plays an important role in self-esteem, saying that when people feel good about their appearance, they exude more confidence as well.

The Southern California health and beauty medical group says that due to advances in medical technology, improving one’s looks has never been easier to achieve. When it comes to video conferencing, Beverly Hills Physicians notes that what most individuals come to worry about are facial lines, wrinkles, and sagging skin. The clinic says that these can all be treated both through traditional facelifts that as well as through nonsurgical treatments such as Botox or other injectables. What most people once assumed was reserved for Hollywood elites and the like in years past has increasingly become accessible to the everyday individual, offering everyone the ability to put their best face forward.

Interested readers who would like more information about Botox or other services offered by Beverly Hills Physicians can call 1-310-620-7911 or visit the clinic’s website at https://www.beverlyhillsphysicians.com/. Virtual consultations are currently available.

Share article on social media or email:

David Teng Appointed as Nations Info Corp President


“I am excited to welcome David to the Nations Info team,” Tim Chin, CEO said. “His entrepreneurial mindset, track record of success and his ‘superstar’ career make him an ideal leader to build on the great work that this team has built so far. I am even more optimistic about Nation Info’s future success when a talent as highly regarded as David joins us.”

Most recently, Teng served as the Vice President and General Manager of Ebates where he built their Asia business from scratch generating over $350m in gross merchandise volume in 5 years. He built a team of nearly 100 people in 4 Asian Pacifc countries and established business direction, new product development, marketing strategies with necessary HR, finance, and legal support. Prior to Ebates, Teng also worked as the Director of Marketing and Product Management, Asia for Living Social, and VP of Marketing, China for Groupon. He also served on the Board of Fanli Inc for the last 3 years. Teng holds a Bachelor of Computer Science degree from University of California Berkeley and a Master of Business Administration from MIT Sloan School of Management.

“I am excited to lead this extraordinary company as Nations Info’s President,” said Teng. “I look forward to working closely with our exceptional executive team, along with Tim. The opportunity that lies ahead for us is enormous. We have a talented team and I am honored to help lead us forward.”

About Nations Info Corp

Founded in 2005, Nations Info Corp (http://www.NationsInfoCorp.com) is a leading online provider of real estate and financial information services to consumers, investors, and professionals. The company’s overarching objective is to aggregate and synthesize massive amounts of data, which is otherwise difficult to find and interpret, into formats on its websites which are easy to access, use, and ultimately empowering for its customers. Our goal is to present information through our websites which can help our customers make informed decisions to identify opportunities to improve their lives, protect their identity and create personal connections to enhance their businesses and personal network.

Share article on social media or email:

Learn How to Flatten the Autism Curve at the World’s Largest, Virtual, Free, Autism Summit


News Image

Past attendees say that AutismOne continues to offer the most progressive information on the bigger picture affecting families with autism.

With the latest statistics from the Centers for Disease Control and Prevention citing 1 child in 54 with an autism diagnosis, parents, professionals, and members of the public are looking for the latest information on cutting-edge therapies and treatments to help children and adults with autism. To fulfill this need, registration is open for the online AutismOne Virtual Summit, with FREE first-run sessions, running May 20 through May 24, 2020.

Ed Arranga, AutismOne’s president and co-founder said, “Children with autism get better, and many recover when given the proper treatments and therapies. When the underlying comorbidities of autism are properly addressed, the individual’s body can begin healing, paving the way for improved learning, function, skills, and behavior.”

Robert F. Kennedy, Jr., will deliver the keynote, Thursday, May 21, joined by over 100 of the world’s leading autism experts. The AutismOne Virtual Summit will cover key issues such as ADHD and biomedical research and treatments, as well as the COVID-19 outbreak and much more.

The AutismOne Conference has been the largest and most comprehensive annual autism conference internationally since 2003, covering all domains of concern to the widest range of the autism community.

Experience the virtual person-to-person networking and learning with professionals and parents at the AutismOne Virtual Summit, where science, hope, and recovery meet. LIVE video sessions include real-time question-and-answer portions, small-group networking among attendees, and the most personal virtual experience available, utilizing the latest technologies. Parents, therapists, professionals, and students will have the opportunity to engage in conversations that cultivate meaningful relationships and obtain the skills, knowledge, and certainty to transform the lives of kids and families.

In addition, the Virtual Exhibit Hall will showcase products and services from exhibitors specializing in addressing the specific needs of individuals with autism.

Past attendees say that AutismOne continues to offer the most progressive information on the bigger picture affecting families with autism.

The AutismOne Virtual Summit website has full details about the sessions, exhibit halls, and virtual networking opportunities at this year’s event. Interested parties can visit the website at https://AutismOneVirtualSummit.org.

Share article on social media or email:

American Physician Partners Growth Trend Continues with the Addition of Nine Emergency Medicine Management Contracts in Indiana


John Rutledge, President & CEO, American Physician Partners

“We are excited that more hospitals are recognizing the value we bring to systems in terms of standardization of care across multiple facilities, improved metrics, and an unwavering focus on delivering exceptional patient care to every patient, every time.”

Officials with American Physician Partners (“APP”), a leader in emergency medicine and hospital medicine management services, are pleased to announce the company is continuing its expansion in Indiana with nine new emergency medicine management contracts. To ensure continuity of service, the transition will occur over a period of several months starting May 1.

American Physician Partners will assume responsibility for the emergency department staffing and management for the following nine Franciscan Health facilities in Indiana:

  •     Franciscan Health Crown Point (Crown Point)
  •     Franciscan Health Michigan City (Michigan City)
  •     Franciscan Emergency Center Chesterton (Chesterton)
  •     Franciscan Health Munster (Munster)
  •     Franciscan Health Dyer (Dyer)
  •     Franciscan Health Hammond (Hammond)
  •     Franciscan Health Lafayette East (Lafayette)
  •     Franciscan Health Crawfordsville (Crawfordsville)
  •     Franciscan Health Rensselaer (Rensselaer)


Franciscan Health is a faith-based health system that operates 12 hospitals and more than 250 medical practices throughout Indiana and Illinois. Its emergency network includes Level III Trauma Centers, Chest Pain Center accreditation, and Stroke Center accreditation.

“American Physician Partners stood out among all those considered because of APP’s focus on patient experience in the emergency department,” said Franciscan Health Crown Point president and CEO Daniel McCormick, M.D. “Their proven expertise with trauma, chest pain, and stroke center accreditation are well aligned with our priorities and delivery of care within our community.”

“We were looking for a partner that valued the same things we did: relationships, the patient experience, and quality of care,” said Dean Mazzoni, president and CEO of Franciscan Health Michigan City. “APP has worked hard to keep our existing team of high-caliber physicians and advanced practice professionals in place, and that was important to us.”

“American Physician Partners is excited to partner with Franciscan Health to expand our footprint in Indiana,” said John Rutledge, president & CEO, American Physician Partners. “We are excited that more hospitals are recognizing the value we bring to systems in terms of standardization of care across multiple facilities, improved metrics, and an unwavering focus on delivering exceptional patient care to every patient, every time.”

About American Physician Partners

Headquartered in Brentwood, Tennessee, American Physician Partners was founded in 2015 to provide a better alternative to hospitals for their clinical outsourcing needs. Since its inception, the company has grown to approximately 160 care sites and has become a recognized leader in the provision of exceptional emergency medicine and hospital medicine management services to hospitals and healthcare systems nationwide. APP has earned its 100 percent client retention rate by remaining true to its purpose of exceeding the expectations of its patients, providers and hospital partners. Learn more at http://www.appartners.com.

Share article on social media or email:

Clinical Wearable Biostrap Launches COVID-19 Study


Biostrap is launching a COVID-19 study that aims to provide a deeper understanding of this novel virus, its early signs, symptoms and even potential long-term effects.

The clinical-grade wearable is inviting all of its users to participate in tracking how COVID-19 impacts human physiology and has partnered with medical professionals at the UCLA School of Medicine and Tulane University to best analyze that data. All participants’ data will be kept anonymous and confidential. Additionally, Biostrap is also donating up to 100 devices to track COVID-19 patients for the purpose of better understanding the progression of the virus.

“No other wearable I am aware of has the same level of informative detail enabling me to collect and dissect the clinical data than Biostrap,” says Dr. Nassir Marrouche, Professor of Medicine at Tulane University, noting that life during and after COVID-19 is going to be different than it was before; wearables and telemedicine are the inevitable reality of medicine.

Remote monitoring is an increasingly important aspect of managing the current health pandemic. Being the most advanced, science-based platform, Biostrap is on a mission to improve global health. Its clinically validated biometric measurements such as heart rate variability, heart rate, oxygen saturation and respiratory rate can be key to monitoring the early signs, progression and regression of COVID-19.

“We are observing significant multi-organ damage post-COVID-19,” Dr. Marrouche says. “The blast in inflammation associated with COVID-19 is leading to short- and long-term organ or system damage. We are working to quantify this damage, at least in the cardiovascular system.”

Biostrap captures high-fidelity, raw PPG (photoplethysmography) waveforms that allow for an in-depth analysis of one’s health. These waveforms are the same kind that doctors use to evaluate their patients’ heart health.

“There’s a lot of data that can be predictive from raw PPG data for example well before any symptoms develop,” says Sameer Sontakey, CEO and Founder of Biostrap. “Each biometric we measure is influenced to a degree by COVID-19.”

It can help understand the infected patient’s continuous biometric behavior, including heart rate, heart rate variability, blood oxygen saturation, sleep patterns and respiratory rate.

“The raw PPG waveform provides tremendous clinical value,” says Dr. Marrouche, adding that “we can apply analysis of PPG to predict severe clinical outcomes like strokes, heart failure or hospitalizations. Also, PPG analysis would help early detect or even prevent disease.”

“We want to use the data we’re collecting in a way that’s meaningful,” says Sontakey. “Biostrap is a science-based platform, so let’s use the platform for good and allow people to work with us in a research capacity.”

About Biostrap

Biostrap is a science-driven platform developed to improve and optimize human health. Gathering data through their clinically validated wrist-worn device, Biostrap utilizes machine learning to provide actionable data to improve sleep, recovery and performance. In addition to providing an individualized approach to consumers via their app and web dashboard, Biostrap also delivers remote monitoring resources for medical and fitness professionals; as well as clinical researchers.

Biostrap measures heart rate variability, heart rate, respiratory rate, blood oxygen saturation, sleep stages and more than 100 activities and exercises. With the addition of external heart rate monitors, the Biostrap app captures real-time heart rate and heart rate variability, while the shoe pod can track gait, cadence, repetitions and velocity.

Share article on social media or email:

Importance of Rapid Lyme Disease Testing To Be Discussed in Free Webinar Hosted by Industry-Leading Quidel Corporation


News Image

As America is painfully learning through the current coronavirus pandemic, reliable testing with quick and accurate results is the key to stopping a disease in its tracks and providing time-sensitive treatment to the afflicted.

With Lyme season once again beginning and as many as 400,000 Americans likely to be impacted by this disease, Quidel Corporation is hosting a free educational webinar on May 13 to discuss options and clinical applications when testing for Lyme disease.

Quidel is a California-based diagnostic healthcare manufacturer and one of the nation’s leaders in developing rapid diagnostic health solutions. It is also the company behind the innovative Sofia 2 in-office Lyme test that provides a patient as well as his or her physician with indicative results within minutes as opposed to days, which has historically been the norm. Performed in the privacy of a doctor’s office or local clinic, it is also the only test that can get results from a simple finger prick of blood.

Lyme disease is a bacterial infection that is spread when people are bitten by an infected deer tick. Unlike a mosquito bite where people know immediately if they have been bitten, one of the challenges with Lyme disease is that symptoms usually will not appear for two to six weeks and may appear in a low-visibility area of the body such as in hair, an underarm or groin. At that point, typical symptoms include fever, headache, fatigue, joint pain, weakness in the limbs, and often a characteristic skin rash with a bull’s-eye pattern. With appropriate antibiotic treatment, most people with Lyme disease recover completely; but the key is catching it early, and that means not hesitating to get tested.

Conducting the webinar will be Sean McCloy, M.D., a national thought leader who practices internal medicine with an expertise in Lyme disease at the Integrative Health Center of Maine in Portland, Maine. Dr. McCloy will discuss Lyme diagnostic and treatment guidelines and testing options and will outline a newer, faster way to help physicians diagnose and treat Lyme disease. Getting rapid results is not only important to those who test positive but given that the vast majority of patients’ tests are negative, getting results quickly means discernable peace of mind for consumers and removes a significant weight off their shoulders. Not having to wait days or more for test results also allows physicians and nurse practitioners to rapidly treat patients by quickly pursuing other testing if deemed necessary for diagnosis and treatment of Lyme disease.

Among those expected to attend the webinar are representatives of physician office laboratories, urgent care centers and pediatric practices plus any other physicians, allied health professionals and healthcare researchers interested in the subject. The May 13 webinar will take place from 9-10 a.m. (PT). To register, click quidel.com/webinars.

About Quidel Corporation

Quidel Corporation serves to enhance the health and well-being of people around the globe through the development of diagnostic solutions that can lead to improved patient outcomes and provide economic benefits to the healthcare system. Quidel’s products aid in the detection and diagnosis of many critical diseases and conditions including not only Lyme disease but, among others, influenza, respiratory syncytial virus, strep A, herpes, pregnancy, thyroid disease and fecal occult blood. Quidel’s research and development engine is also developing a continuum of diagnostic solutions from advanced immunoassay to molecular diagnostic tests to further improve the quality of healthcare in physicians’ offices and hospital and reference laboratories. For more information about Quidel, visit quidel.com.

Share article on social media or email:

ILC Dover Reacts to Rising Demand for PPE During the COVID-19 Crisis, Rapidly Launches a New Healthcare Respirator Innovation


ILC Dover employees ramp up production of respirator equipment, including the new EZ BioHood, for frontline healthcare workers.

“The company has always supplied critical personal protective equipment products to these frontline workers. What has changed is the demand for the products – up 1,000 percent over last year.”

At the start of 2020 ILC Dover was well positioned for continued growth – delivering innovative solutions for a wide range of industries including pharmaceutical and biopharmaceutical manufacturing, healthcare, food and beverage, personal care, chemical, aerospace and government agencies. A month into the new decade, it was clear to company leadership that they would have to adapt to unexpected circumstances: novel coronavirus was going to impact the world – and ILC Dover’s customers – in a big way.

The company was already fulfilling orders from top healthcare facilities nationwide for its top-of-the-line powered air purifying respirators (PAPRs), which redefined how healthcare employees mitigate the risk of exposure to hazardous pathogens. The Sentinel XL® HP PAPR systems were designed, using customer feedback, to provide superior protection for those workers who confront infectious disease every day – the frontline personnel who would be at highest risk of exposure to COVID-19.

Healthcare Industry Demand for PPE Skyrockets

By mid-February, demand for personal protective equipment (PPE) began to spike. By the end of March, demand for PPE was up more than 1,000 percent over the previous year. ILC Dover was shipping orders to healthcare customers across the country at rapid pace, and quickly recognized it would have to increase production to match the exponential growth in demand.

“ILC Dover is no stranger to creating solutions under immense pressure,” says ILC Dover President and CEO Fran DiNuzzo. “The company protected American astronauts on the moon and kept healthcare workers safe during Ebola and SARS outbreaks. In addition to the work we are doing to support healthcare workers, we support pharmaceutical customers developing revolutionary medicines; customers who are focused on food production and supply key products for the critical defense and the security of the nation. Our culture of innovation is designed to respond with highly engineered solutions in each customer’s moment of need.”

Maintaining Supply Across Critical Industries

With the first inklings of a shifting reality, in early February ILC Dover leadership adjusted operations to protect workers at each of their global locations from what would later be labeled a pandemic. At the same time, as demand for PPE surpassed the previous year’s orders by 1,000 percent, ILC Dover began ramping up production to 30 times the previous monthly output.

It became clear that the healthcare hood supply for our PAPR product would limit the company’s ability to meet customer needs for the lifesaving respirators. Frontline healthcare workers needed a highly protective and comfortable hood that was also easy and intuitive to put on and then remove without concerns for contamination of the user. With the dramatic surge in demand, the new product had to be immediately producible using materials and equipment currently in the ILC Dover Delaware facility, or readily available.

In a matter of weeks, the ILC Dover team developed a new hood to support their healthcare respirator system for use during the COVID-19 outbreak. EZ BioHood™ prototypes have already been tested by loyal customers and approved by NIOSH in record time. The company is now shipping orders for the new hood, just over a month after starting design.

“The ILC Dover team has shown extraordinary commitment to helping our healthcare customers do their job effectively and safely,” says Vice President of Marketing Paul Cannon. “The company has always supplied critical personal protective equipment products to these frontline workers. What has changed is the demand for the products – up 1,000 percent over last year.”

Throughout the dramatic ramp-up of PPE production, ILC Dover continues to supply pharmaceutical customers worldwide with the equipment they need to develop and produce new drugs or ramp up production – many also responding to increased demand due to COVID-19. Customers involved in food production, and those ensuring national security, have also experienced no interruption, despite economy-wide supply chain disruptions.

What Healthcare Workers Say

“We’re very grateful to the thousands of healthcare workers treating patients in this pandemic – putting their lives on the line for others,” says DiNuzzo. “We have these heroes in mind.”

Cannon shared a nurse’s response upon receiving a PAPR from ILC Dover: “I arrived home at midnight to see it (PAPR) lying on my steps. It was a pleasant birthday gift and you probably facilitated in saving my life. My family and I are truly appreciative of your effort and would like to thank you. Words cannot explain. I now have the confidence of providing care to those who really need it with my own PPE. Thank you.”

Says hospital nurse practitioner Kate from Nebraska Biocontainment Unit, “We are taking care of patients with COVID-19, patients needing intense medical care and lifesaving procedures. As we expand and open new units, our providers are asking for the level of protection that PAPRs provide.”

In fast-paced, high-pressure hospital scenarios, providers must be able to easily put on and take off the PAPR without any risk of contamination. ILC Dover engineers designed EZ BioHood in response to customer requests, including: Is the hood intuitive, easy to train for first-time use? Can it be worn by providers with facial hair, head coverings or varying facial structures? Does it need to be fit-tested? Healthcare providers also appreciate the new hood’s wide field of vision, so they can connect with patients face to face, and the ability to use equipment like a stethoscope while wearing the PAPR. It must be comfortable for long days on their feet.

Eileen Searle, Biothreats Program Manager at Massachusetts General Hospital reflected, “Our respiratory protection for staff treating COVID-19 patients includes N95 respirators and PAPRs, and given the scope of the COVID-19 pandemic we continue to expand the number of staff who are using respiratory protection. We appreciate ILC Dover’s ongoing innovation in PPE to adapt to specific needs as we take care of patients and ensure we are able to keep all of our care team members safe.”

Bayhealth President and CEO Terry M. Murphy, FACHE, says, “PAPRs are essential to keeping our staff safe. We were very happy when ILC Dover reached out to see if we needed any PAPRs, as we were starting to run low on our supply. As a result of them stepping in, we have been able to continue to support and protect our staff who are caring for COVID-19 patients.”

Beyond the hospital setting, where respirators are used in treating seriously ill patients, other healthcare providers have concerns. As the economy reopens, they will continue to deal with infectious disease. Physician Deborah Wingel runs a busy primary care practice in Hockessin, Delaware. “During the current COVID-19 pandemic, there have been significant challenges to keeping ourselves, our staff, and our patients safe,” says Dr. Wingel. “Most of these issues revolve around access to enough PPE.”

Dr. Wingel recognized that over 9,000 healthcare providers have been infected with the coronavirus. “When patients get sick, their first contact is their primary care doctor,” she said. “I need to be able to examine and treat safely. When I learned more about ILC Dover PAPR systems, I felt it would be the perfect solution to our problems with protecting healthcare workers from COVID-19. This product offers us 100x the protection of an N95 mask, and I can engage directly with my patients through the clear shield. It requires certain protocols to put on and remove it, but it is worth it to me. (It will give me peace of mind while examining my daily patients.) The Sentinel PAPR system is made right here in Delaware – less than one hour from my practice.”

The New Normal – After COVID-19

“We anticipate high demand for PPE at least into the summer,” says DiNuzzo, “and then while we expect a slowing demand as this crisis subsides, demand will decrease to a level higher than before COVID-19, due to a new recognition of need for re-supply at our nation’s hospitals and strengthening of our national strategic supply. The healthcare industry will want to prepare for everything from the routine infectious diseases they treat to the next pandemic.”

One thing that will never change? The adaptability and determination of innovators to solve the problems that face our society. No matter what ‘normal’ comes to mean, ILC Dover’s engineers and production team are ready to take it head-on.

About ILC Dover

ILC Dover is a world-leader in the innovative design and production of engineered flexible protective solutions, for pharmaceutical and biopharmaceutical, flood protection, personal protection, bulk packaging, and aerospace industries. Our customers will attest to our relentless dedication to high value products, advanced technology, and responsive service, as our visionary solutions have improved efficiency while safeguarding people, product, and infrastructure in hazardous conditions through flexible protective solutions since 1947. For more information, visit ilcdover.com.

Kyowa Hakko USA Introduces New VELOX® Patented Performance Blend


News Image

Kyowa Hakko USA announces the launch of VELOX® Patented Performance Blend, a clinically studied combination of Kyowa’s L-Citrulline and Kyowa’s L-Arginine that has been shown to increase Nitric Oxide production and to boost Nitric Oxide levels more rapidly than L-Arginine alone*.

The unique blend comes backed by 4 U.S. Patents – U.S. Patent 8,609,735, U.S. Patent 9,060,980, U.S. Patent 9,622,998, and U.S. Patent 10,052,298 titled, “Rapid-acting, blood-arginine-level-increasable oral preparation comprising citrulline and arginine” which covers the use of ingredients and related compounds within the blend. The effective dosage requires a minimum of 1.2 grams of Kyowa’s L-Citrulline and 1.2 grams of Kyowa’s L-Arginine, and a ratio of 1:1 of Kyowa L-Citrulline and Kyowa L-Arginine to support claims.

“With four U.S. patents and clinical studies to support it, introducing this new performance blend to the market from Kyowa Hakko strengthens our position as a company that is committed to ensuring our customers always receive efficacious, ultra-pure, high-quality ingredients, guaranteed,” comments Elyse Lovett, MS, MBA, Senior Marketing Manager of Kyowa Hakko U.S.A. Inc.

VELOX® Patented Performance Blend is clinically studied to rapidly increase blood Arginine levels*, increase power output*, reduce muscle soreness*, and synergistically increase blood Arginine levels*. It is a patented Nitric Oxide booster* that is manufactured through Kyowa Hakko’s innovative fermentation process, ensuring purity and no added chemicals. The new branded ingredient is made in the USA, is non-GMO, and vegetarian. Citrulline is self-affirmed GRAS, Arginine is an FDA approved food additive therefore VELOX® Patented Performance Blend can be used in a wide variety of food, beverage, and dietary supplement applications.

“We couldn’t be more thrilled to incorporate VELOX® into Kyowa Hakko’s line of innovative branded health ingredients,” remarks Lovett, “We look forward to supporting our quest to improve health through our clinically-studied ingredients for nutraceuticals and food products worldwide.”

Customers interested in including VELOX® into their next product can contact Kyowa Hakko through their site form at https://kyowa-usa.com/branded-ingredients/velox-patented-performance-blend . Media interested in setting up an interview with a Kyowa Hakko representative to discuss the VELOX Patented Performance Blend, please contact Sara White: sara@adinnyc.com or 914-621.1323.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

About VELOX Patented Performance Blend:

VELOX® Patented Performance Blend is a combination of Kyowa’s L-Citrulline and Kyowa’s L-Arginine. The effective dosage requires a minimum of 1.2 grams of Kyowa’s L-Citrulline and 1.2 grams of Kyowa’s L-Arginine, and a ratio of 1:1 of Kyowa L-Citrulline and Kyowa L-Arginine to support claims. VELOX® Patented Performance Blend is clinically studied to rapidly increase blood Arginine levels*, increase power output*, reduce muscle soreness*, and synergistically increase blood Arginine levels*. VELOX ® is protected by four US Patents: U.S. Patent 8,609,735, U.S. Patent 9,060,980, U.S. Patent 9,622,998, and U.S. Patent 10,052,298

About Kyowa Hakko USA:

Kyowa Hakko USA is the North & South American office for Kyowa Hakko Bio Co. Ltd., an international health ingredients manufacturer and world leader in the development, manufacturing, and marketing of pharmaceuticals, nutraceuticals and food products. For more information visit Kyowa-USA.com.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

References

1.    Suzuki T. et al. Biosci Biotechnol Biochem. 81(2): 372-375, 2017

2.    Suzuki I. et al. Eur J Appl Physiol. 2019

Share article on social media or email:

Cloudticity Named to ChannelE2E Top 100 Vertical Market MSPs: 2020 Edition


There’s no greater reward than being able to support healthcare when it needs us most — but being recognized by ChannelE2E again this year is pretty nice too.

Cloudticity has been named to After Nines Inc.’s ChannelE2E Top 100 Vertical Market MSPs list and research (http://www.channelE2E.com/top100) for 2020. The annual list and research (hashtag: #Top100MSP) identify and honor the top 100 managed services providers (MSPs) in healthcare, legal, government, financial services, manufacturing and additional vertical markets.

The Top 100 Vertical Market MSPs rankings are based on ChannelE2E’s Q4 2019 and January 2020 readership survey, and ChannelE2E’s vertical market industry coverage. MSPs featured throughout the list and research leverage deep vertical market expertise to drive annual recurring revenues (ARR) in specific market segments.

This year’s research revealed several key MSP market trends, including:

  • Honorees generated a combined $1.12 billion in vertical market annual recurring revenue (ARR) in 2019, up from $699.1 million in 2018. The surge involved organic growth combined with accelerating merger and acquisition (M&A) activity.
  • The most successful vertical market MSPs are zeroing in on financial services and healthcare, while MSPs in the legal and manufacturing sectors also showed particularly strong growth.
  • The Top 100 Vertical Market MSPs now manage more than 2.8 million users across their customer sites in 2019, up from 2.6 million in 2018.
  • MSPs consider their top vertical market technology partners to be Microsoft (56%), Dell Technologies (22%), Cisco Systems (21%), Datto (19%), ConnectWise (11%) and Ingram Micro (11%).

Cloudticity was ranked among the top vertical market MSPs in healthcare.

 

“The healthcare industry is currently in crisis. Cloudticity has been heavily involved supporting customers to leverage healthcare data and cloud-native technologies to help inform the emergency response and recovery,” said Gerry Miller, Founder & CEO of Cloudticity. “There’s no greater reward than being able to support healthcare when it needs us most — but being recognized by ChannelE2E again this year is pretty nice too.”

 

“After Nines Inc. congratulates Cloudticity on this honor,” said Amy Katz, CEO of After Nines Inc. “Vertical market MSPs are uniquely positioned to assist their customers with automation, cybersecurity, e-commerce and business recovery services during this challenging time for the global economy.”

The ChannelE2E Top 100 Vertical Market MSPs list and research are overseen by Content Czar Joe Panettieri (@JoePanettieri). Find the online list and associated report here: http://www.channelE2E.com/top100

 

About Cloudticity

Founded in 2011, Cloudticity focuses exclusively on helping healthcare organizations improve and reimagine healthcare by unlocking the full potential of cloud innovation. Cloudticity has built some of the largest healthcare systems on the cloud, including the first patient portal on AWS, the first Health Information Exchange, the first FISMA high deployment on AWS GovCloud, and the first Meaningful Use 2 compliance for a large hospital system.

Although Cloudticity started its practice as an MSP and continues to grow that practice, listening to customer needs led to new innovations. Cloudticity Healthcare DataHub™, the next-gen interoperability platform, is currently enabling public health organizations to improve real-time decisions in regards to the COVID-19 response.

As Cloudticity rapidly grows, it stays true to its core mission: to help healthcare companies create a healthier, happier world by enabling incredible innovation and velocity powered by the cloud.

  • For product information contact Cloudticity Director of Marketing Kate Z. Wang, kate.wang@cloudticity.com

About After Nines Inc.

After Nines Inc. provides timeless IT guidance for strategic partners and IT security professionals across ChannelE2E (http://www.ChannelE2E.com) and MSSP Alert (http://www.MSSPAlert.com). ChannelE2E tracks every stage of the IT service provider journey — from entrepreneur to exit. MSSP Alert is the global voice for Managed Security Services Providers (MSSPs).  

  • For sponsorship information contact After Nines Inc. CEO Amy Katz, Amy@AfterNines.com
  • For content and editorial questions contact After Nines Inc. Content Czar Joe Panettieri, Joe@AfterNines.com

Share article on social media or email:

Ventilator Use May Necessitate Alternative Methods of Communication for Patients in Acute Care


Not only do people deserve to have their basic needs met, such as to communicate that they are in pain or request that a loved one is called, but patients may be more likely to have a serious adverse medical event if they cannot communicate with their health care providers.

Augmentative and alternative communication (AAC) can play an important role helping COVID-19 patients communicate their condition and wishes with their medical teams. AAC includes the use of gestures, picture and word boards, and messages on computers or phones to help people communicate more effectively. The need for AAC is heightened by the fact that patients in acute care may not have loved ones around who would normally advocate for their care.

Many COVID-19 patients in serious condition require a mechanical ventilator to help them breathe while in acute care. Although this is intended to be a life-saving measure, ventilator usage can result in complications—short- and long-term. This includes a person’s ability to speak, which can have serious repercussions if not appropriately addressed, according to the American Speech-Language-Hearing Association (ASHA).

“It is essential that everyone have the ability to communicate at all times—and be provided an alternative method of communication if they cannot use speech,” said Theresa Rodgers, MA, CCC-SLP, 2020 ASHA President. “Not only do people deserve to have their basic needs met, such as to communicate that they are in pain or request that a loved one is called, but patients may be more likely to have a serious adverse medical event if they cannot communicate with their health care providers.”

Under typical circumstances, speech-language pathologists can work with patients at their bedside to introduce some form of AAC. However, given the tight restrictions on the number of people (including health care professionals) who interact with COVID-19 patients, this may not be happening routinely.

Patients and their family members should know that they have a right to communicate and that there are effective communication options via AAC. Although many staff members in acute-care settings have some experience with basic AAC, such as picture boards, there may be facilities where that isn’t the case.

In response, an interdisciplinary group of practitioners drawing from the professions of speech-language pathology, nursing, and psychology developed a comprehensive set of free resources for patients and families who require short-term AAC use.

These resources include downloadable communication boards with COVID-19–relevant messages to support patients of different ages and abilities in a critical acute medical setting. Should communication challenges remain, patients can also use these boards beyond the acute-care setting, including by family members interacting with their loved one throughout the recovery process.

To learn more about communication and AAC for people who are now or who were ventilator dependent, visit ASHA’s website here.

About the American Speech-Language-Hearing Association (ASHA)

ASHA is the national professional, scientific, and credentialing association for 211,000 members and affiliates who are audiologists; speech-language pathologists; speech, language, and hearing scientists; audiology and speech-language pathology support personnel; and students. Audiologists specialize in preventing and assessing hearing and balance disorders as well as providing audiologic treatment, including hearing aids. Speech-language pathologists identify, assess, and treat speech and language problems, including swallowing disorders. http://www.asha.org

Share article on social media or email: